Avantium signed capacity reservation agreement with BIOVOX for PEF in pharmaceutical applications

CEO Tom Van Aken and Her Majesty Queen Maxima. Source: Avantium

Avantium, the Dutch company in renewable and circular polymer materials, signed a capacity reservation agreement with BIOVOX, a pioneer in sustainable healthcare plastics. Under this agreement, BIOVOX has committed to using Avantium’s PEF (polyethylene furanoate) in various pharmaceutical applications. This PEF is expected to be produced in a future industrial-scale facility, based on a technology license from Avantium. The multi-year capacity reservation ensures BIOVOX preferred access to PEF volumes produced by Avantium’s future licensee network.

Continue reading →

Evonik launches plant-based squalene to boost vaccine efficacy

wpid-evonik_methionine_singapore.jpg

Evonik has launched a non-animal-derived squalene suitable for vaccines and other pharmaceutical applications. PhytoSquene® is the first known amaranth oil-derived squalene on the market for use in adjuvants in parenteral dosage forms. It meets the demand for a secure commercial supply of non-animal-derived squalene. Non-GMP samples of PhytoSquene® are available immediately with GMP quality to follow in 2023.

Continue reading →

Nouryon joined forces with water treatment company Van Remmen UV Technology

Nouryon joined forces with water treatment company Van Remmen UV Technology on a novel method to address the growing concern of pharmaceutical micropollutants in waste water. The process, which combines the Advanox™ ultraviolet (UV) treatment process from Van Remmen UV Technology and Nouryon’s MicrOx™ hydrogen peroxide, is expected to remove more than 90% of pharmaceutical residues.

Continue reading →